Jeffrey Fernandez

443 total citations
26 papers, 333 citations indexed

About

Jeffrey Fernandez is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Jeffrey Fernandez has authored 26 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Jeffrey Fernandez's work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pneumonia and Respiratory Infections (6 papers). Jeffrey Fernandez is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pneumonia and Respiratory Infections (6 papers). Jeffrey Fernandez collaborates with scholars based in United States, Netherlands and Spain. Jeffrey Fernandez's co-authors include John F. Barrett, Jamese J. Hilliard, Rajesh Devraj, A. Simon Lynch, Mark Cushman, John A. Katzenellenbogen, Darren Abbanat, Robert K. Flamm, Kwasi A. Ohemeng and Jeffrey I. Bernstein and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Bacteriology and Journal of Medicinal Chemistry.

In The Last Decade

Jeffrey Fernandez

23 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Fernandez United States 14 123 97 67 66 56 26 333
Tom Vidmar United States 11 148 1.2× 141 1.5× 130 1.9× 50 0.8× 48 0.9× 24 504
Kenji Namba Japan 10 161 1.3× 112 1.2× 70 1.0× 105 1.6× 66 1.2× 18 446
Ruby Pelingon Australia 8 192 1.6× 39 0.4× 101 1.5× 79 1.2× 54 1.0× 10 424
Nuran Yuluğ Türkiye 11 100 0.8× 71 0.7× 65 1.0× 143 2.2× 136 2.4× 47 469
S. Ken Tanaka United States 9 98 0.8× 90 0.9× 47 0.7× 117 1.8× 42 0.8× 11 359
Anna M. Snelling United Kingdom 9 165 1.3× 116 1.2× 33 0.5× 28 0.4× 91 1.6× 13 441
M Zawada Poland 8 131 1.1× 81 0.8× 36 0.5× 60 0.9× 46 0.8× 23 329
T Iwahi Japan 10 129 1.0× 61 0.6× 98 1.5× 93 1.4× 131 2.3× 13 702
Tongying Nie China 10 115 0.9× 41 0.4× 72 1.1× 44 0.7× 28 0.5× 27 323
Kathleen D. Triplett United States 10 180 1.5× 128 1.3× 37 0.6× 21 0.3× 16 0.3× 14 315

Countries citing papers authored by Jeffrey Fernandez

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Fernandez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Fernandez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Fernandez more than expected).

Fields of papers citing papers by Jeffrey Fernandez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Fernandez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Fernandez. The network helps show where Jeffrey Fernandez may publish in the future.

Co-authorship network of co-authors of Jeffrey Fernandez

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Fernandez. A scholar is included among the top collaborators of Jeffrey Fernandez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Fernandez. Jeffrey Fernandez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernandez, Jeffrey, et al.. (2026). Nitrile RC≡N Triple Bond Cleavage by a Dicopper Nitrite Complex with N 2 Elimination and Formation of RCO 2 Carboxylate Ligands. Journal of the American Chemical Society. 148(3). 3455–3461.
2.
Fernandez, Jeffrey, et al.. (2025). Synthesis of Metallostannylenes from Transition Metal Polyhydride Complexes. Journal of the American Chemical Society. 147(42). 38732–38742.
3.
Fernandez, Jeffrey, Afshin Javadi, Simon J. Teat, Thomas R. Cundari, & T. Don Tilley. (2024). Synthetically Reversible, Proton-Mediated Nitrite N–O Bond Cleavage at a Dicopper Site. Journal of the American Chemical Society. 146(50). 34962–34969. 5 indexed citations
4.
Chan, Rita, Peter T. Buckley, William E. Sause, et al.. (2019). Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus. Science Translational Medicine. 11(475). 21 indexed citations
5.
Queenan, Anne Marie, David J. Dowling, Kellen C. Faé, et al.. (2018). Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Vaccine. 37(1). 80–89. 14 indexed citations
6.
Dowling, David J., Holly Sanders, Spencer E. Brightman, et al.. (2016). A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity. Frontiers in Immunology. 7. 562–562. 23 indexed citations
7.
Jordan, Robert E., Jeffrey Fernandez, Randall J. Brezski, et al.. (2016). A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity. Immunology Letters. 172. 29–39. 9 indexed citations
8.
Queenan, Anne Marie, et al.. (2014). The mouse intranasal challenge model for potency testing of whole-cell pertussis vaccines. Expert Review of Vaccines. 13(10). 1265–1270. 7 indexed citations
9.
Fernandez, Jeffrey, Darren Abbanat, Wenchi Shang, et al.. (2012). Synergistic Activity of Ceftobiprole and Vancomycin in a Rat Model of Infective Endocarditis Caused by Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 56(3). 1476–1484. 24 indexed citations
10.
Fernandez, Jeffrey, et al.. (2011). Efficacy of a New Fluoroquinolone, JNJ-Q2, in Murine Models of Staphylococcus aureus and Streptococcus pneumoniae Skin, Respiratory, and Systemic Infections. Antimicrobial Agents and Chemotherapy. 55(12). 5522–5528. 15 indexed citations
11.
Hilliard, Jamese J., LeRoy Hall, Darren Abbanat, et al.. (2010). Comparative Effects of Carbapenems on Bacterial Load and Host Immune Response in aKlebsiella pneumoniaeMurine Pneumonia Model. Antimicrobial Agents and Chemotherapy. 55(2). 836–844. 16 indexed citations
12.
Fernandez, Jeffrey, Jamese J. Hilliard, Darren Abbanat, et al.. (2009). In Vivo Activity of Ceftobiprole in Murine Skin Infections Due toStaphylococcus aureusandPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 54(1). 116–125. 13 indexed citations
13.
Hilliard, Jamese J., Jeffrey Fernandez, Mark J. Macielag, et al.. (2009). In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457. Antimicrobial Agents and Chemotherapy. 53(5). 2028–2033. 16 indexed citations
14.
Ferrer, C., Alfonso Rodríguez‐Baeza, José Luı́s Abad, Jeffrey Fernandez, & Jorge L. Alió del Barrio. (2008). Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis. British Journal of Ophthalmology. 92(5). 678–682. 9 indexed citations
15.
Fernandez, Jeffrey. (2007). In Vivo Activity of Ceftobiprole in a Pseudomonal Murine Skin Infection Model. 1 indexed citations
16.
Kanojia, Ramesh M., William V. Murray, Jeffrey I. Bernstein, et al.. (1999). 6-Oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems. Bioorganic & Medicinal Chemistry Letters. 9(20). 2947–2952. 13 indexed citations
17.
Fernandez, Jeffrey, et al.. (1999). Comparison of Efficacies of Oral Levofloxacin and Oral Ciprofloxacin in a Rabbit Model of a Staphylococcal Abscess. Antimicrobial Agents and Chemotherapy. 43(3). 667–671. 19 indexed citations
18.
Weidner‐Wells, Michele A., Jeffrey Fernandez, Stephanie A. Fraga‐Spano, et al.. (1998). DNA gyrase inhibitory activity of ellagic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 8(1). 97–100. 16 indexed citations
19.
Devraj, Rajesh, John F. Barrett, Jeffrey Fernandez, John A. Katzenellenbogen, & Mark Cushman. (1996). ChemInform Abstract: Design, Synthesis, and Biological Evaluation of Ellipticine‐Estradiol Conjugates.. ChemInform. 27(49). 1 indexed citations
20.
Devraj, Rajesh, John F. Barrett, Jeffrey Fernandez, John A. Katzenellenbogen, & Mark Cushman. (1996). Design, Synthesis, and Biological Evaluation of Ellipticine−Estradiol Conjugates. Journal of Medicinal Chemistry. 39(17). 3367–3374. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026